Pharma-Bio Serv (PBSV) Other Non-Current Assets (2010 - 2026)
Pharma-Bio Serv posted quarterly Other Non-Current Assets of $120783.0 for Q1 2026, down 46.45% year-on-year from $225558.0 in Q1 2025, and little changed on a QoQ basis from $120754.0 in Q4 2025.
Pharma-Bio Serv (PBSV) has 16 years of Other Non-Current Assets data on file, last reported at $120783.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 46.45% year-over-year to $120783.0; the trailing twelve-month figure through Jan 2026 stood at $120783.0 (down 46.45% YoY), and the FY2025 full-year result was $120754.0, down 46.47% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $120783.0, roughly flat from $120754.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $353294.0 in Q1 2022 and bottomed at $111665.0 in Q4 2023.
- The 5-year median for Other Non-Current Assets is $130874.0 (2022), against an average of $174368.5.
- The widest annual swing landed in 2023, when Other Non-Current Assets slumped 63.14%; it then jumped 102.06% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $130874.0 in 2022, then retreated by 14.68% to $111665.0 in 2023, then soared by 102.03% to $225599.0 in 2024, then plunged by 46.47% to $120754.0 in 2025, then climbed by 0.02% to $120783.0 in 2026.
- The last three Other Non-Current Assets figures came in at $120783.0 (Q1 2026), $120754.0 (Q4 2025), and $225649.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 62.26 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 5.80 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 80.09 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 15.26 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 1.92 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 8.09 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 2.62 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 20.55 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 54.81 Mn |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | 120,783.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 120,783.00 |
| Oct 31, 2025 | 120,754.00 |
| Jul 31, 2025 | 225,649.00 |
| Apr 30, 2025 | 225,643.00 |
| Jan 31, 2025 | 225,558.00 |
| Oct 31, 2024 | 225,599.00 |
| Jul 31, 2024 | 125,594.00 |
| Apr 30, 2024 | 111,674.00 |
| Jan 31, 2024 | 111,691.00 |
| Oct 31, 2023 | 111,665.00 |
| Jul 31, 2023 | 130,161.00 |
| Apr 30, 2023 | 130,172.00 |
| Jan 31, 2023 | 131,040.00 |
| Oct 31, 2022 | 130,874.00 |
| Jul 31, 2022 | 130,932.00 |
| Apr 30, 2022 | 353,181.00 |
| Jan 31, 2022 | 353,294.00 |
| Oct 31, 2021 | 353,354.00 |
| Jul 31, 2021 | 353,407.00 |
| Apr 30, 2021 | 270,303.00 |
| Jan 31, 2021 | 270,321.00 |
| Oct 31, 2020 | 270,242.00 |
| Jul 31, 2020 | 430,737.00 |
| Apr 30, 2020 | 368,631.00 |
| Jan 31, 2020 | 367,797.00 |
| Oct 31, 2019 | 367,437.00 |
| Jul 31, 2019 | 367,547.00 |
| Apr 30, 2019 | 419,055.00 |
| Jan 31, 2019 | 417,762.00 |
| Oct 31, 2018 | 418,495.00 |
| Jul 31, 2018 | 418,737.00 |
| Apr 30, 2018 | 422,081.00 |
| Jan 31, 2018 | 423,180.00 |
| Oct 31, 2017 | 1.16 Mn |
| Jul 31, 2017 | 29,698.00 |
| Apr 30, 2017 | 30,060.00 |
| Jan 31, 2017 | 35,563.00 |
| Oct 31, 2016 | 35,579.00 |
| Jul 31, 2016 | 33,079.00 |
| Oct 31, 2015 | 18,256.00 |
| Oct 31, 2013 | 16,891.00 |
| Apr 30, 2013 | 28,038.00 |
| Jan 31, 2013 | 25,755.00 |
| Oct 31, 2012 | 25,592.00 |
| Jul 31, 2012 | 28,374.00 |
| Apr 30, 2012 | 28,892.00 |
| Jan 31, 2012 | 24,501.00 |
| Oct 31, 2011 | 28,306.00 |
| Jul 31, 2011 | 20,207.00 |
| Oct 31, 2010 | 33,364.00 |